Objective: To evaluate the prevalence of anemia, iron deficiency and iron deficiency anemia in a cohort of children.
Introduction
The World Health Organization (WHO), 1 2007, at various scopes, and shows that the median data for anemia prevalence in this age group were 53%, and the highest prevalence was found in children younger than 24 months. 4 In Brazil, there are no data on the national or regional prevalence of ID and few studies have assessed the prevalence of ID or ID anemia (IDA) in children. The results show an IDA prevalence of approximately 50%. [5] [6] [7] [8] However, the few studies that included other parameters to determine ID did not specify the different age groups. Therefore, the present study aimed to evaluate the prevalence of anemia, ID and IDA in a cohort of children followed from birth at ages 12-16 months and 3-4 years.
Methods
This is a cohort study nested in a randomized field trial of children recruited at birth at Hospital Centenário, the only hospital in the city of São Leopoldo, southern Brazil, only in the sectors providing care through the Brazilian public Unified Health System (SUS). Newborns eligible for the study had birth weight greater than 2,500 g and gestational age greater than 37 weeks. Mothers were invited to participate after being provided with detailed information on the study protocol, which included differences between intervention and control groups for implementation of a nutrition intervention program during the infant's first year of life. Sample size was calculated for a larger study, based on a frequency of exclusive breastfeeding up to 4 months old of 21.6% in the control group and an estimated 65% difference in the frequency of this practice between groups after intervention. Other parameters for this calculation were: 80% power and 95% confidence interval, which determined a sample size of 177 children in each group, totaling 354 children. Assuming 25% of losses, 500 motherchild pairs were recruited to reach the minimum sample size required. The initial study methodology has been described in detail elsewhere. 9 The intervention program did not influence the prevalence of anemia among children, allowing them to be analyzed for this purpose regardless of to which group the child belonged. Children were assessed at age 12-16 months (n = 397) and later at age 3-4 years (n = 354). The sample for assessment of iron status was smaller due to losses caused by parents' refusal or because blood collection was not possible. Between the first and second assessments, no nutritional intervention was performed that could influence the nutritional status of children.
Assessment of iron status
All children evaluated at age 12-16 months and later at Univariate analysis expresses the frequency of variables as proportion. Pearson's chi-square test was used for categorical variables, which evaluated the association between sex and the outcomes assessed. P values < 0.05 were considered to be statistically significant.
Ethical considerations
The research project was approved by the Research Ethics (Table 2) .
Discussion
The results of the present study showed that ID was associated with anemia in 95% of cases of children assessed at age 12-16 months, although at age 3-4 years this proportion was below 20%. The WHO 1,2 estimates that half of anemia cases are caused by ID and that the prevalence of ID is 2.5 times that of anemia. However, our study showed that this concept does not apply to children older than 2 years. Studies conducted with children in countries other than Brazil exhibited results similar to those presented in this article, with low serum retinol and folic acid levels being observed among children with anemia. 11, 12 Research conducted in Northeast Brazil with pregnant women In Brazil, a recent nationwide study showed low frequency of sickle cell anemia in the population studied. 3 It is also noteworthy that microcytosis is not present in sickle cell anemia, except in cases of co-inheritance of thalassemia. A study conducted in Rio Grande do Sul, the southernmost state in high SF levels and low hematopoietic activity. 21, 22 The absence of CRP measurement in the first evaluation of children could be a limitation of the study. CRP measurements aim to identify children with infections and to exclude these children from the analysis, since they may have increased ferritin levels as a result of infection and, thus, lead to a higher incidence of false-negative results for ID. Since ID prevalence in this age group (12-16 months) was 95%, not excluding children with infections did not affect the conclusions of this study. For ethical reasons, all children who were diagnosed with anemia at age 12-16 months received a prescription for ferrous sulfate for a 3-month period. Since there was no follow-up of children after this period, the level of treatment adherence was not assessed.
Therefore, since the interval between the first and second anemia assessment was approximately 2 years, we do not believe that low ID prevalence as a cause of anemia in children aged 3-4 years can be attributed to this factor.
Another aspect that may explain the low prevalence of ID among preschoolers is their ability to consume larger amounts of food -and, consequently, higher amounts of iron, especially of food made from wheat flour and corn flour, which are currently fortified -than when they were 12-16 months old.
We also highlight the higher prevalence of anemia and IDA among boys aged 12-16 months, which may be explained by the accelerated growth velocity during the first year of life, since growth velocity is higher in boys when compared to girls during this period. This process increases iron requirement, which is not often supplied by the diet due to the low bioavailability of dietary iron. At age 3-4 years, growth velocity is constant and much lower, thus no longer being an additional risk factor for IDA. 23 The 
Conclusion
The results showed that ID, considered the most prevalent nutritional deficiency in the world, is the leading cause of anemia in children aged 12-16 months, but not at age 3-4 years. Therefore, it does not seem appropriate to use the prevalence of anemia as a proxy for IDA, regardless of age. Thus, further studies are warranted to explore the causes of low Hb levels in children with adequate iron stores and to elucidate other causes of anemia in children older than 2 years.
